1
|
Yessirkepov M, Bekaryssova D, Mutalipova G, Narkabulov A. Trends in the incidence of musculoskeletal diseases in Kazakhstan in 2011-2020: an information-analytical study. Rheumatol Int 2023:10.1007/s00296-023-05343-0. [PMID: 37173546 PMCID: PMC10180672 DOI: 10.1007/s00296-023-05343-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2023] [Accepted: 05/05/2023] [Indexed: 05/15/2023]
Abstract
According to the World Health Organization, there is an increase in the incidence of musculoskeletal diseases worldwide. The problem of this group of diseases is that they are associated with the onset of temporary and permanent disability. A number of studies have demonstrated an increase in the incidence of musculoskeletal diseases in the US, Canada, Australia, and European countries. The current informational and analytical study was aimed to reflect on related morbidity trends in Kazakhstan. We analyzed data on the incidence of diseases of the musculoskeletal system in 2011-2020. Ten annual statistical yearbooks of the Ministry of Health of Kazakhstan were used to obtain data. The results showed an increase in the total incidence of musculoskeletal diseases of 304,492 cases between 2011 and 2020. Primary incidence of musculoskeletal disorders in the whole population increased by a factor of 1.5. The incidence rate of musculoskeletal diseases increased in the age group over 18 years and in the 0-14 years' child group. A comparative analysis of morbidity figures for rural and urban populations was also presented. An increase in the incidence of musculoskeletal diseases in both populations was observed. Finally, comparative data analysis on morbidity across Central Asian countries was provided. This information-analytical study shows that the incidence of musculoskeletal disorders is steadily increasing in Kazakhstan. The scientific community should pay attention to this trend to prevent further increases in the incidence of musculoskeletal disorders.
Collapse
Affiliation(s)
- Marlen Yessirkepov
- Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan
| | - Dana Bekaryssova
- Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.
| | - Gulmira Mutalipova
- Department of Biology and Biochemistry, South Kazakhstan Medical Academy, Shymkent, Kazakhstan
| | | |
Collapse
|
2
|
Reuter K, Haupt C, Molto A, Cope A, van Vollenhoven RF, Elewaut D, Lories R, McInnes IB. Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre. RMD Open 2022; 8:e002456. [PMID: 35714997 PMCID: PMC9207999 DOI: 10.1136/rmdopen-2022-002456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Accepted: 05/17/2022] [Indexed: 11/07/2022] Open
Abstract
Herein, we describe the Research Centre launched by the European Alliance of Associations for Rheumatology (EULAR) in 2020. The Centre aims to facilitate collaborative research on rheumatic and musculoskeletal diseases (RMD) across Europe. RMDs disable millions of people in Europe and worldwide. Despite progress with improved therapeutics and strategic interventions in several RMDs, there are no cures, and their collective impact remains substantial. Access to RMD-related care, policies prioritizing RMDs, and related research, education, training, and funding differ significantly across European countries. Building a new equipoise in opportunity and capacity across Europe will facilitate optimal understanding of those different factors that influence the epidemiology, pathogenesis, treatment, and outcomes in RMDs. The EULAR Research Centre aims to address the significant barriers to accelerating RMD research across Europe. It provides an RMD research roadmap of unmet needs, expert services, infrastructures, networks, research resources, training, education, and mentoring. It will place RMD research in the ideal position to benefit from forthcoming remarkable advances in digital, biological, and social science anticipated in the coming decades.
Collapse
Affiliation(s)
- Katja Reuter
- European Alliance of Associations for Rheumatology (EULAR), Zurich, Switzerland
- Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, New York, USA
| | - Carina Haupt
- European Alliance of Associations for Rheumatology (EULAR), Zurich, Switzerland
| | - Anna Molto
- Department of Rheumatology, Cochin Hospital, APHP, Paris, France
- INSERM U-1153, Center for Research in Epidémiology and StatisticS (CRESS), Université Paris Cité, Paris, France
| | - Andrew Cope
- Centre for Rheumatic Diseases, King's College London, London, UK
| | - Ronald F van Vollenhoven
- Department of Rheumatology and Clinical Immunology, Amsterdam Rheumatology and Immunology Center ARC, Amsterdam, Netherlands
| | - Dirk Elewaut
- Department of Rheumatology, Ghent University Hospital, Ghent, Belgium
- VIB Center for Inflammation Research, Ghent University, Ghent, Belgium
| | - Rik Lories
- Division of Rheumatology, University Hospitals Leuven, Leuven, Belgium
- Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Belgium
| | - Iain B McInnes
- Institute of Infection, Immunity and Inflammation, University of Glasgow, College of Medical, Veterinary and Life Sciences, Glasgow, UK
| |
Collapse
|
3
|
Hristova M, Kamenarska Z, Dzhebir G, Nikolova S, Hristova R, Mihova K, Vinkov A, Georgiev T, Pozharashka J, Kaneva R, Savov A, Koundurdjiev A, Dourmishev L. The role of IL-17 rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 SNPs and IL-17A serum levels in patients with lupus nephritis. Rheumatol Int 2021; 41:2205-2213. [PMID: 34554306 DOI: 10.1007/s00296-021-04996-z] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Accepted: 09/13/2021] [Indexed: 12/14/2022]
Abstract
Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease and polymorphisms in the cytokine genes and their receptors are thought to influence its development. The aim of this case-control study was to investigate the association of the IL-17A rs2275913, IL-17RC rs708567 and TGFB1 rs1800469 polymorphisms with SLE, its clinical manifestations and the polymorphisms influence on the IL-17A serum levels. Altogether 59 SLE patients with lupus nephritis and 95 healthy controls were genotyped by TaqMan assay. Serum levels were determined by Human IL-17A Platinum ELISA kit. From the studied polymorphisms, only TGFB1 T allele was found to be associated with SLE. Within the patient group, IL-17A GG genotype and TGFB1 -509T allele showed an association with the neurological disease and IL-17RC CC genotype appeared to be associated with lupus arthritis. The IL17A serum levels in the SLE and control groups (7.24 pg/ml and 5.76 pg/ml, respectively) did not show any statistical difference. A weak correlation between IL17A levels and SLEDAI-2K was observed. Our results indicate that IL-17A rs2275913, IL-17RCrs708567 and TGFB1 rs1800469 polymorphisms might play a role in the susceptibility and the clinical manifestations of SLE and IL-17A serum levels should be monitored in the course of the disease. The identification of subsets of SLE with an IL-17-driven disease could improve the therapeutic approach leading to more precise personalized treatment.
Collapse
Affiliation(s)
- Maria Hristova
- Clinic of Nephrology, Department of Internal Medicine, University Hospital St Ivan Rilski, Medical University-Sofia, Sofia, Bulgaria.
| | - Zornitsa Kamenarska
- Molecular Medicine Center, Medical University-Sofia, 2 Zdrave Street, 1431, Sofia, Bulgaria
| | - Gyulnas Dzhebir
- Molecular Medicine Center, Medical University-Sofia, 2 Zdrave Street, 1431, Sofia, Bulgaria
| | - Svetla Nikolova
- Molecular Medicine Center, Medical University-Sofia, 2 Zdrave Street, 1431, Sofia, Bulgaria
| | - Rozalia Hristova
- Department of Ophthalmology, Medical University-Sofia, Alexandrovska Hospital, 1 GeorgiSofijski Street, 1431, Sofia, Bulgaria
| | - Kalina Mihova
- Molecular Medicine Center, Medical University-Sofia, 2 Zdrave Street, 1431, Sofia, Bulgaria
| | - Anton Vinkov
- Hôpitaux Drôme Nord, 607 avenue Geneviève de Gaulle-Anthonioz, 26102, Romans-sur-Isère, France
| | - Tsvetoslav Georgiev
- Clinic of Rheumatology, First Department of Internal Medicine, University Hospital "St Marina", Medical University-Varna, 9002, Varna, Bulgaria
| | - Joana Pozharashka
- Department of Dermatology and Venereology, Medical University-Sofia, 1 Georgi Sofijski Street, 1431, Sofia, Bulgaria
| | - Radka Kaneva
- Molecular Medicine Center, Medical University-Sofia, 2 Zdrave Street, 1431, Sofia, Bulgaria.,Department of Medical Chemistry and Biochemistry, Medical University -Sofia, 2 Zdrave Street, 1431, Sofia, Bulgaria
| | - Alexey Savov
- National Genetic Laboratory, Medical University Sofia, 2 Zdrave Street, 1431, Sofia, Bulgaria
| | - Atanas Koundurdjiev
- Clinic of Nephrology, Department of Internal Medicine, University Hospital St Ivan Rilski, Medical University-Sofia, Sofia, Bulgaria
| | - Lyubomir Dourmishev
- Department of Dermatology and Venereology, Medical University-Sofia, 1 Georgi Sofijski Street, 1431, Sofia, Bulgaria
| |
Collapse
|
4
|
Ahmed S, Zimba O, Gasparyan AY. Moving towards online rheumatology education in the era of COVID-19. Clin Rheumatol 2020; 39:3215-3222. [PMID: 32939569 PMCID: PMC7494363 DOI: 10.1007/s10067-020-05405-9] [Citation(s) in RCA: 32] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Revised: 09/06/2020] [Accepted: 09/12/2020] [Indexed: 12/28/2022]
Abstract
The coronavirus disease-2019 (COVID-19) pandemic has unsettled conventional medical education, hastening a switch to digital platforms and open-access publishing. Rheumatology is a fast evolving academic discipline that stands to gain by this switch. Most rheumatology textbooks are now available in digital formats, and these are complemented with live updating educational hubs such as UpToDate and ClinicalKey. Emerging topics of COVID-19 on these proprietary platforms are now freely available to all specialists. Social media channels, particularly Twitter, are becoming major players in the era of COVID-19 by offering online journal clubs, enabling fast dissemination of influential articles, and facilitating interactive education. Indexed rheumatology journals, in turn, aid online education by opening access to recommendations and other materials that are rapidly changing research and practice worldwide. Research peer review additionally offers learning experience to novice and seasoned researchers and authors. Global rheumatology societies have online learning resources, which are changing their format and geographic reach to meet the changing needs in the times of pandemic. While online teaching lacks emotional connections between mentors and mentees, switch to a more interactive format of education and regular contacts may partly solve the issue. Rheumatologists can take the lead in these challenging times and contribute more to online scholarly activities which are aimed to maintain and enrich education. Key Points • Disparities in rheumatology education are likely to be widened during the COVID-19 pandemic. • Barriers to rheumatology education include limited number of instructors and their limited experience in online teaching. • Online textbooks, didactic materials of indexed rheumatology journals, and frequently updated online educational hubs such as UpToDate serve as a foundation of online rheumatology education. • Online rheumatology education is enriched by peer review and social media activities, which are becoming major players in the time of the COVID-19 pandemic.
Collapse
Affiliation(s)
- Sakir Ahmed
- Department of Clinical Immunology & Rheumatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, 751024 India
| | - Olena Zimba
- Department of Internal Medicine No. 2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
| | - Armen Yuri Gasparyan
- Departments of Rheumatology and Research and Development, Russells Hall Hospital, Dudley Group NHS Foundation Trust (Teaching Trust of the University of Birmingham, UK), Pensnett Road, Dudley, West Midlands DY1 2HQ UK
| |
Collapse
|
5
|
Doskaliuk B, Zimba O, Yatsyshyn R, Kovalenko V. Rheumatology in Ukraine. Rheumatol Int 2020; 40:175-182. [PMID: 31898762 DOI: 10.1007/s00296-019-04504-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Accepted: 12/17/2019] [Indexed: 12/31/2022]
Abstract
Rheumatology in Ukraine is based on established research and clinical infrastructure that enable the integration with regional and global societies. This article overviews current state of Ukrainian rheumatology, important steps toward expanding clinical settings, and opportunities for strengthening cooperation of local rheumatologists and patients with rheumatic diseases with related international societies. The main achievements and some challenges encountered by the Association of Rheumatologists of Ukraine are outlined. The Association supports continuing medical education of local specialists and explores options for advancing research and publishing in rheumatology. One of the main challenges still remains the creation of registries of patients with rheumatic diseases and expansion of activities of public societies with interest in combating rheumatic diseases. The issue of inadequate access to immunobiological therapies is also highlighted.
Collapse
Affiliation(s)
- Bohdana Doskaliuk
- Academician Ye. M. Neiko Department of Internal Medicine #1, Clinical Immunology and Allergology, Ivano-Frankivsk National Medical University, Halytska Str. 2, Ivano-Frankivsk, 76000, Ukraine.
| | - Olena Zimba
- Department of Internal Medicine #2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
| | - Roman Yatsyshyn
- Academician Ye. M. Neiko Department of Internal Medicine #1, Clinical Immunology and Allergology, Ivano-Frankivsk National Medical University, Halytska Str. 2, Ivano-Frankivsk, 76000, Ukraine
| | - Volodymyr Kovalenko
- Department of Therapy and Rheumatology, P.L. Shupyk National Medical Academy of Postgraduate Education, Kiev, Ukraine
| |
Collapse
|
6
|
Sandhu VK, Hojjati M, Blanco I. Healthcare disparities in rheumatology: the role of education at a global level. Clin Rheumatol 2019; 39:659-666. [PMID: 31602534 DOI: 10.1007/s10067-019-04777-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Revised: 09/05/2019] [Accepted: 09/09/2019] [Indexed: 01/12/2023]
Abstract
All fields of medicine are victim to health inequity worldwide, including rheumatology. While the health system is a key proponent to health access for all, other social determinants of health also impact world health. We describe herein the current state of global healthcare disparities in rheumatology and attempts at optimizing graduate medical education and resources for optimized healthcare, international research collaborations and a future of universal health equity. We performed a comprehensive search through Pubmed using the following keywords: healthcare disparities, medical education, access to care, community health.Key Points• Healthcare disparities are ubiquitous globally, including the field of rheumatology.• The heterogeneity of global healthcare disparities emphasizes the importance of addressing unmet needs at a regional level.• A standardized approach to incorporating healthcare disparities education in the medical field is lacking. Intervening at this level provides a foundation of increasing provider awareness of regional healthcare disparities so as to establish a framework of addressing such disparities in a culturally competent manner.
Collapse
Affiliation(s)
- Vaneet Kaur Sandhu
- Division of Rheumatology, Department of Medicine, Loma Linda University, 11234 Anderson Street, MC-1516, Loma Linda, CA, 92354, USA.
| | - Mehrnaz Hojjati
- Division of Rheumatology, Department of Medicine, Loma Linda University, 11234 Anderson Street, MC-1516, Loma Linda, CA, 92354, USA
| | - Irene Blanco
- Division of Rheumatology, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY, 10461, USA
| |
Collapse
|
7
|
Clinical characteristics and disability in patients with knee osteoarthritis: real world experience from Bulgaria. Reumatologia 2019; 57:78-84. [PMID: 31130745 PMCID: PMC6532116 DOI: 10.5114/reum.2019.84812] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2019] [Accepted: 04/05/2019] [Indexed: 01/04/2023] Open
Abstract
Objectives Although knee osteoarthritis (KOA) is a leading cause of impaired functioning among older adults globally, little is still known about the complex mechanisms of disability accumulation in these patients. The aim of the study was to analyze the clinical parameters of patients with KOA in a Bulgarian population and to determine which of these clinical characteristics define disability to the greatest extent. Material and methods Patients aged 40–80 years with symptomatic KOA were included. The assessment tools for pain, clinical disease severity, and disability were the pain visual analogue scale (VAS) and disease-specific questionnaires: Algofunctional Index of Lequesne, Western Ontario and McMaster Universities OA Index (WOMAC), and the Health Assessment Questionnaire-Disability Index (HAQ-DI), respectively. Radiographs of the knees were obtained and graded according to the Kellgren-Lawrence (KL) system. Results One hundred and thirty-two patients (81% women) participated in the study. The median values of VAS (mm), WOMAC, Lequesne, and HAQ-DI scores were 52, 37.5, 11, 0.88, respectively. Men had milder disease, resulting in lower VAS, WOMAC, Lequesne, and HAQ-DI scores and less structural damage compared to women (p < 0.05). WOMAC index correlated positively with age of the patients but not with duration of the complaints. Patients with severe and very severe pain did not differ in their HAQ-DI, disease severity and KL grading. WOMAC physical function score and Lequesne index were independent predictors for the HAQ-DI in patients with KOA. Conclusions Bulgarian patients with KOA had moderate disability which showed a strong relationship with physical function of WOMAC and disease severity. Multiple layers of causality coexist to determine the knee pain in Bulgarian patients with KOA.
Collapse
|